APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fluoxetine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Fluoxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchFluoxetine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Fluoxetine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Fluoxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fluoxetine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Fluoxetine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Fluoxetine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fluoxetine include Teva, Sun Pharmaceutical, Suzhou YUSHI Pharmaceutical, Sandoz, Mylan, Changzhou Siyao Pharmaceutical, Wockhardt, Torrent Pharmaceuticals and Pharmaceutical Associates Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fluoxetine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fluoxetine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fluoxetine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fluoxetine market size, projected growth trends, production technologies, key applications, and end-use industries.

Fluoxetine Segment by Company

Teva

Sun Pharmaceutical

Suzhou YUSHI Pharmaceutical

Sandoz

Mylan

Changzhou Siyao Pharmaceutical

Wockhardt

Torrent Pharmaceuticals

Pharmaceutical Associates Inc.

Lannett Company

Dr.Reddy's Laboratories

Aurobindo Pharma

Alvogen

Alembic Pharmaceuticals

Fluoxetine Segment by Type

Capsules

Oral Solution

Tablets

Fluoxetine Segment by Application

Depression

Bulimia Nervosa

Obsessive–Compulsive Disorder

Panic Disorder

Others

Fluoxetine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluoxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fluoxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluoxetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fluoxetine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fluoxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fluoxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fluoxetine Industry Trends Table 2. Fluoxetine Industry Drivers Table 3. Fluoxetine Industry Opportunities and Challenges Table 4. Fluoxetine Industry Restraints Table 5. Global Fluoxetine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fluoxetine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fluoxetine Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Fluoxetine Sales Market Share by Manufacturers Table 9. Global Fluoxetine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Fluoxetine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fluoxetine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fluoxetine Manufacturers, Product Type & Application Table 13. Global Fluoxetine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fluoxetine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsules Table 17. Major Manufacturers of Oral Solution Table 18. Major Manufacturers of Tablets Table 19. Global Fluoxetine Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Fluoxetine Sales by Type (2021-2026) & (W Units) Table 21. Global Fluoxetine Sales by Type (2027-2032) & (W Units) Table 22. Global Fluoxetine Sales Market Share by Type (2021-2026) Table 23. Global Fluoxetine Sales Market Share by Type (2027-2032) Table 24. Global Fluoxetine Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Fluoxetine Revenue by Type (2021-2026) & (W Units) Table 26. Global Fluoxetine Revenue by Type (2027-2032) & (W Units) Table 27. Global Fluoxetine Revenue Market Share by Type (2021-2026) Table 28. Global Fluoxetine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Depression Table 30. Major Manufacturers of Bulimia Nervosa Table 31. Major Manufacturers of Obsessive–Compulsive Disorder Table 32. Major Manufacturers of Panic Disorder Table 33. Major Manufacturers of Others Table 34. Global Fluoxetine Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Fluoxetine Sales by Application (2021-2026) & (W Units) Table 36. Global Fluoxetine Sales by Application (2027-2032) & (W Units) Table 37. Global Fluoxetine Sales Market Share by Application (2021-2026) Table 38. Global Fluoxetine Sales Market Share by Application (2027-2032) Table 39. Global Fluoxetine Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 40. Global Fluoxetine Revenue by Application (2021-2026) & (W Units) Table 41. Global Fluoxetine Revenue by Application (2027-2032) & (W Units) Table 42. Global Fluoxetine Revenue Market Share by Application (2021-2026) Table 43. Global Fluoxetine Revenue Market Share by Application (2027-2032) Table 44. Global Fluoxetine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Fluoxetine Sales by Region (2021-2026) & (W Units) Table 46. Global Fluoxetine Sales Market Share by Region (2021-2026) Table 47. Global Fluoxetine Sales Forecasted by Region (2027-2032) & (W Units) Table 48. Global Fluoxetine Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. North America Fluoxetine Sales by Country (2021-2026) & (W Units) Table 51. North America Fluoxetine Sales by Country (2027-2032) & (W Units) Table 52. Europe Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Europe Fluoxetine Sales by Country (2021-2026) & (W Units) Table 54. Europe Fluoxetine Sales by Country (2027-2032) & (W Units) Table 55. Asia Pacific Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Asia Pacific Fluoxetine Sales by Country (2021-2026) & (W Units) Table 57. Asia Pacific Fluoxetine Sales by Country (2027-2032) & (W Units) Table 58. South America, Middle East and Africa Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. South America, Middle East and Africa Fluoxetine Sales by Country (2021-2026) & (W Units) Table 60. South America, Middle East and Africa Fluoxetine Sales by Country (2027-2032) & (W Units) Table 61. Global Fluoxetine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Fluoxetine Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Fluoxetine Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Fluoxetine Revenue Market Share by Region (2021-2026) Table 65. Global Fluoxetine Revenue Market Share by Region (2027-2032) Table 66. Teva Company Information Table 67. Teva Business Overview Table 68. Teva Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Teva Fluoxetine Product Portfolio Table 70. Teva Recent Development Table 71. Sun Pharmaceutical Company Information Table 72. Sun Pharmaceutical Business Overview Table 73. Sun Pharmaceutical Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sun Pharmaceutical Fluoxetine Product Portfolio Table 75. Sun Pharmaceutical Recent Development Table 76. Suzhou YUSHI Pharmaceutical Company Information Table 77. Suzhou YUSHI Pharmaceutical Business Overview Table 78. Suzhou YUSHI Pharmaceutical Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Suzhou YUSHI Pharmaceutical Fluoxetine Product Portfolio Table 80. Suzhou YUSHI Pharmaceutical Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sandoz Fluoxetine Product Portfolio Table 85. Sandoz Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Mylan Fluoxetine Product Portfolio Table 90. Mylan Recent Development Table 91. Changzhou Siyao Pharmaceutical Company Information Table 92. Changzhou Siyao Pharmaceutical Business Overview Table 93. Changzhou Siyao Pharmaceutical Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Changzhou Siyao Pharmaceutical Fluoxetine Product Portfolio Table 95. Changzhou Siyao Pharmaceutical Recent Development Table 96. Wockhardt Company Information Table 97. Wockhardt Business Overview Table 98. Wockhardt Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Wockhardt Fluoxetine Product Portfolio Table 100. Wockhardt Recent Development Table 101. Torrent Pharmaceuticals Company Information Table 102. Torrent Pharmaceuticals Business Overview Table 103. Torrent Pharmaceuticals Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Torrent Pharmaceuticals Fluoxetine Product Portfolio Table 105. Torrent Pharmaceuticals Recent Development Table 106. Pharmaceutical Associates Inc. Company Information Table 107. Pharmaceutical Associates Inc. Business Overview Table 108. Pharmaceutical Associates Inc. Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Pharmaceutical Associates Inc. Fluoxetine Product Portfolio Table 110. Pharmaceutical Associates Inc. Recent Development Table 111. Lannett Company Company Information Table 112. Lannett Company Business Overview Table 113. Lannett Company Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Lannett Company Fluoxetine Product Portfolio Table 115. Lannett Company Recent Development Table 116. Dr.Reddy's Laboratories Company Information Table 117. Dr.Reddy's Laboratories Business Overview Table 118. Dr.Reddy's Laboratories Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Dr.Reddy's Laboratories Fluoxetine Product Portfolio Table 120. Dr.Reddy's Laboratories Recent Development Table 121. Aurobindo Pharma Company Information Table 122. Aurobindo Pharma Business Overview Table 123. Aurobindo Pharma Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Aurobindo Pharma Fluoxetine Product Portfolio Table 125. Aurobindo Pharma Recent Development Table 126. Alvogen Company Information Table 127. Alvogen Business Overview Table 128. Alvogen Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Alvogen Fluoxetine Product Portfolio Table 130. Alvogen Recent Development Table 131. Alembic Pharmaceuticals Company Information Table 132. Alembic Pharmaceuticals Business Overview Table 133. Alembic Pharmaceuticals Fluoxetine Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Alembic Pharmaceuticals Fluoxetine Product Portfolio Table 135. Alembic Pharmaceuticals Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Fluoxetine Distributors List Table 139. Fluoxetine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Fluoxetine Product Image Figure 2. Global Fluoxetine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fluoxetine Market Size (2021-2032) & (US$ Million) Figure 4. Global Fluoxetine Sales (2021-2032) & (W Units) Figure 5. Global Fluoxetine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Fluoxetine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsules Image Figure 9. Oral Solution Image Figure 10. Tablets Image Figure 11. Global Fluoxetine Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Fluoxetine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Fluoxetine Sales Market Share by Type (2021-2032) Figure 14. Global Fluoxetine Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Fluoxetine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Fluoxetine Revenue Market Share by Type (2021-2032) Figure 17. Depression Image Figure 18. Bulimia Nervosa Image Figure 19. Obsessive–Compulsive Disorder Image Figure 20. Panic Disorder Image Figure 21. Others Image Figure 22. Global Fluoxetine Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Fluoxetine Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Fluoxetine Sales Market Share by Application (2021-2032) Figure 25. Global Fluoxetine Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Fluoxetine Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Fluoxetine Revenue Market Share by Application (2021-2032) Figure 28. North America Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 29. North America Fluoxetine Sales Market Share by Country (2021-2032) Figure 30. U.S. Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Canada Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Mexico Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Fluoxetine Sales Market Share by Country (2021-2032) Figure 35. Germany Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 36. France Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 37. U.K. Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Italy Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Netherlands Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Fluoxetine Sales Market Share by Country (2021-2032) Figure 42. China Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Japan Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South Korea Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Southeast Asia Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 46. India Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Australia Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Fluoxetine Sales Market Share by Country (2021-2032) Figure 50. Brazil Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South Africa Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Saudi Arabia Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Turkey Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Argentina Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 55. UAE Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Egypt Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Chile Fluoxetine Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Global Fluoxetine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Fluoxetine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Fluoxetine Revenue (2021-2032) & (US$ Million) Figure 61. North America Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Fluoxetine Revenue (2021-2032) & (US$ Million) Figure 63. Europe Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Fluoxetine Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Fluoxetine Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Fluoxetine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Fluoxetine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Oral Solution
  • Tablets
Applications
  • Depression
  • Bulimia Nervosa
  • Obsessive–Compulsive Disorder
  • Panic Disorder
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Suzhou YUSHI Pharmaceutical
  • Sandoz
  • Mylan
  • Changzhou Siyao Pharmaceutical
  • Wockhardt
  • Torrent Pharmaceuticals
  • Pharmaceutical Associates Inc.
  • Lannett Company
  • Dr.Reddy's Laboratories
  • Aurobindo Pharma
  • Alvogen
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fluoxetine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fluoxetine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fluoxetine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fluoxetine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fluoxetine Market Dynamics
  1. 2.1 Fluoxetine Industry Trends
  2. 2.2 Fluoxetine Industry Drivers
  3. 2.3 Fluoxetine Industry Opportunities and Challenges
  4. 2.4 Fluoxetine Industry Restraints
3 Fluoxetine Market by Manufacturers
  1. 3.1 Global Fluoxetine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fluoxetine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fluoxetine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fluoxetine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fluoxetine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fluoxetine Manufacturers, Product Type & Application
  7. 3.7 Global Fluoxetine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fluoxetine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fluoxetine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fluoxetine Tier 1, Tier 2, and Tier 3
4 Fluoxetine Market by Type
  1. 4.1 Fluoxetine Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Oral Solution
  4. 4.1.3 Tablets
  5. 4.2 Global Fluoxetine Sales by Type
  6. 4.2.1 Global Fluoxetine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Fluoxetine Sales by Type (2021-2032)
  8. 4.2.3 Global Fluoxetine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Fluoxetine Revenue by Type
  10. 4.3.1 Global Fluoxetine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Fluoxetine Revenue by Type (2021-2032)
  12. 4.3.3 Global Fluoxetine Revenue Market Share by Type (2021-2032)
5 Fluoxetine Market by Application
  1. 5.1 Fluoxetine Application Introduction
  2. 5.1.1 Depression
  3. 5.1.2 Bulimia Nervosa
  4. 5.1.3 Obsessive–Compulsive Disorder
  5. 5.1.4 Panic Disorder
  6. 5.1.5 Others
  7. 5.2 Global Fluoxetine Sales by Application
  8. 5.2.1 Global Fluoxetine Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Fluoxetine Sales by Application (2021-2032)
  10. 5.2.3 Global Fluoxetine Sales Market Share by Application (2021-2032)
  11. 5.3 Global Fluoxetine Revenue by Application
  12. 5.3.1 Global Fluoxetine Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Fluoxetine Revenue by Application (2021-2032)
  14. 5.3.3 Global Fluoxetine Revenue Market Share by Application (2021-2032)
6 Global Fluoxetine Sales by Region
  1. 6.1 Global Fluoxetine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fluoxetine Sales by Region (2021-2032)
  3. 6.2.1 Global Fluoxetine Sales by Region (2021-2026)
  4. 6.2.2 Global Fluoxetine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fluoxetine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fluoxetine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fluoxetine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fluoxetine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fluoxetine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fluoxetine Revenue by Region
  1. 7.1 Global Fluoxetine Revenue by Region
  2. 7.1.1 Global Fluoxetine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fluoxetine Revenue by Region (2021-2026)
  4. 7.1.3 Global Fluoxetine Revenue by Region (2027-2032)
  5. 7.1.4 Global Fluoxetine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fluoxetine Revenue (2021-2032)
  8. 7.2.2 North America Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fluoxetine Revenue (2021-2032)
  11. 7.3.2 Europe Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fluoxetine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fluoxetine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fluoxetine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Fluoxetine Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Fluoxetine Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Suzhou YUSHI Pharmaceutical
  14. 8.3.1 Suzhou YUSHI Pharmaceutical Company Information
  15. 8.3.2 Suzhou YUSHI Pharmaceutical Business Overview
  16. 8.3.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Suzhou YUSHI Pharmaceutical Fluoxetine Product Portfolio
  18. 8.3.5 Suzhou YUSHI Pharmaceutical Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Fluoxetine Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Fluoxetine Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Changzhou Siyao Pharmaceutical
  32. 8.6.1 Changzhou Siyao Pharmaceutical Company Information
  33. 8.6.2 Changzhou Siyao Pharmaceutical Business Overview
  34. 8.6.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Changzhou Siyao Pharmaceutical Fluoxetine Product Portfolio
  36. 8.6.5 Changzhou Siyao Pharmaceutical Recent Developments
  37. 8.7 Wockhardt
  38. 8.7.1 Wockhardt Company Information
  39. 8.7.2 Wockhardt Business Overview
  40. 8.7.3 Wockhardt Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wockhardt Fluoxetine Product Portfolio
  42. 8.7.5 Wockhardt Recent Developments
  43. 8.8 Torrent Pharmaceuticals
  44. 8.8.1 Torrent Pharmaceuticals Company Information
  45. 8.8.2 Torrent Pharmaceuticals Business Overview
  46. 8.8.3 Torrent Pharmaceuticals Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharmaceuticals Fluoxetine Product Portfolio
  48. 8.8.5 Torrent Pharmaceuticals Recent Developments
  49. 8.9 Pharmaceutical Associates Inc.
  50. 8.9.1 Pharmaceutical Associates Inc. Company Information
  51. 8.9.2 Pharmaceutical Associates Inc. Business Overview
  52. 8.9.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharmaceutical Associates Inc. Fluoxetine Product Portfolio
  54. 8.9.5 Pharmaceutical Associates Inc. Recent Developments
  55. 8.10 Lannett Company
  56. 8.10.1 Lannett Company Company Information
  57. 8.10.2 Lannett Company Business Overview
  58. 8.10.3 Lannett Company Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lannett Company Fluoxetine Product Portfolio
  60. 8.10.5 Lannett Company Recent Developments
  61. 8.11 Dr.Reddy's Laboratories
  62. 8.11.1 Dr.Reddy's Laboratories Company Information
  63. 8.11.2 Dr.Reddy's Laboratories Business Overview
  64. 8.11.3 Dr.Reddy's Laboratories Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dr.Reddy's Laboratories Fluoxetine Product Portfolio
  66. 8.11.5 Dr.Reddy's Laboratories Recent Developments
  67. 8.12 Aurobindo Pharma
  68. 8.12.1 Aurobindo Pharma Company Information
  69. 8.12.2 Aurobindo Pharma Business Overview
  70. 8.12.3 Aurobindo Pharma Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aurobindo Pharma Fluoxetine Product Portfolio
  72. 8.12.5 Aurobindo Pharma Recent Developments
  73. 8.13 Alvogen
  74. 8.13.1 Alvogen Company Information
  75. 8.13.2 Alvogen Business Overview
  76. 8.13.3 Alvogen Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Alvogen Fluoxetine Product Portfolio
  78. 8.13.5 Alvogen Recent Developments
  79. 8.14 Alembic Pharmaceuticals
  80. 8.14.1 Alembic Pharmaceuticals Company Information
  81. 8.14.2 Alembic Pharmaceuticals Business Overview
  82. 8.14.3 Alembic Pharmaceuticals Fluoxetine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Alembic Pharmaceuticals Fluoxetine Product Portfolio
  84. 8.14.5 Alembic Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fluoxetine Value Chain Analysis
  2. 9.1.1 Fluoxetine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fluoxetine Production Mode & Process
  6. 9.2 Fluoxetine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fluoxetine Distributors
  9. 9.2.3 Fluoxetine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst